Alix Alderman

Alix Alderman serves as the Chief Regulatory Officer at Vergent Bioscience since May 2024, with extensive experience in regulatory affairs. Alderman is a Fellow of TOPRA, awarded in 2021, and has held various leadership roles within the organization, including Director of the TOPRA Board and Chair of the North America Leadership Team. As a member of Chief, a network for women executives, Alderman focuses on strengthening female leadership. Previously, Alderman founded Starling Access in 2017, providing consultancy in regulatory science and drug development, and held senior regulatory positions at Neumora, PellePharm, and BridgeBio. Alderman's educational background includes a Bachelor of Science in Exercise Physiology from the University of California, Davis.